New drug selonabant put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a single dose of the experimental drug selonabant in 40 healthy adults aged 18 to 30. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side…
Phase: PHASE1 • Sponsor: Anebulo Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC